103 related articles for article (PubMed ID: 8410993)
1. Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8- difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarb oxylic acid and related derivatives.
Wentland MP; Lesher GY; Reuman M; Gruett MD; Singh B; Aldous SC; Dorff PH; Rake JB; Coughlin SA
J Med Chem; 1993 Sep; 36(19):2801-9. PubMed ID: 8410993
[TBL] [Abstract][Full Text] [Related]
2. Stereo (C7)-dependent topoisomerase II inhibition and tumor growth suppression by a new quinolone, BO-2367.
Yoshinari T; Mano E; Arakawa H; Kurama M; Iguchi T; Nakagawa S; Tanaka N; Okura A
Jpn J Cancer Res; 1993 Jul; 84(7):800-6. PubMed ID: 8396568
[TBL] [Abstract][Full Text] [Related]
3. 5-Amino-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6,8-difluoro-1,4- dihydro-4-oxo-3-quinolinecarboxylic acid (PD 124,816). Synthesis and biological evaluation of a new class of quinolone antibacterials.
Domagala JM; Hagen SE; Hutt MP; Sanchez JP; Sesnie J; Trehan AK
Drugs Exp Clin Res; 1988; 14(7):453-60. PubMed ID: 2853667
[TBL] [Abstract][Full Text] [Related]
4. Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential.
Elsea SH; McGuirk PR; Gootz TD; Moynihan M; Osheroff N
Antimicrob Agents Chemother; 1993 Oct; 37(10):2179-86. PubMed ID: 8257142
[TBL] [Abstract][Full Text] [Related]
5. Placement of alkyl substituents on the C-7 piperazine ring of fluoroquinolones: dramatic differential effects on mammalian topoisomerase II and DNA gyrase.
Gootz TD; McGuirk PR; Moynihan MS; Haskell SL
Antimicrob Agents Chemother; 1994 Jan; 38(1):130-3. PubMed ID: 8141566
[TBL] [Abstract][Full Text] [Related]
6. Quinolone antibacterials: synthesis and biological activity of carbon isosteres of the 1-piperazinyl and 3-amino-1-pyrrolidinyl side chains.
Laborde E; Kiely JS; Culbertson TP; Lesheski LE
J Med Chem; 1993 Jul; 36(14):1964-70. PubMed ID: 8393112
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7 H- pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161).
Coughlin SA; Danz DW; Robinson RG; Klingbeil KM; Wentland MP; Corbett TH; Waud WR; Zwelling LA; Altschuler E; Bales E
Biochem Pharmacol; 1995 Jun; 50(1):111-22. PubMed ID: 7605336
[TBL] [Abstract][Full Text] [Related]
8. 1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.
Domagala JM; Heifetz CL; Hutt MP; Mich TF; Nichols JB; Solomon M; Worth DF
J Med Chem; 1988 May; 31(5):991-1001. PubMed ID: 2834557
[TBL] [Abstract][Full Text] [Related]
9. Quinolone antibacterials containing the new 7-[3-(1-aminoethyl)-1- pyrrolidinyl] side chain: the effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacy.
Domagala JM; Hagen SE; Joannides T; Kiely JS; Laborde E; Schroeder MC; Sesnie JA; Shapiro MA; Suto MJ; Vanderroest S
J Med Chem; 1993 Apr; 36(7):871-82. PubMed ID: 8385225
[TBL] [Abstract][Full Text] [Related]
10. Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group.
Robinson MJ; Martin BA; Gootz TD; McGuirk PR; Osheroff N
Antimicrob Agents Chemother; 1992 Apr; 36(4):751-6. PubMed ID: 1323952
[TBL] [Abstract][Full Text] [Related]
11. Studies on quinolone antibacterials. V. Synthesis and antibacterial activity of chiral 5-amino-7-(4-substituted-3-amino-1-pyrrolidinyl)-6- fluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acids and derivatives.
Yoshida T; Yamamoto Y; Orita H; Kakiuchi M; Takahashi Y; Itakura M; Kado N; Yasuda S; Kato H; Itoh Y
Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1376-86. PubMed ID: 8706143
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial activity of a new series of tetracyclic pyridone carboxylic acids.
Jinbo Y; Kondo H; Inoue Y; Taguchi M; Tsujishita H; Kotera Y; Sakamoto F; Tsukamoto G
J Med Chem; 1993 Sep; 36(18):2621-6. PubMed ID: 8410974
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of a new series of tetracyclic pyridone carboxylic acids.
Jinbo Y; Taguchi M; Inoue Y; Kondo H; Miyasaka T; Tsujishita H; Sakamoto F; Tsukamoto G
J Med Chem; 1993 Oct; 36(21):3148-53. PubMed ID: 8230101
[TBL] [Abstract][Full Text] [Related]
14. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 7-thio-substituted 4-oxoquinoline-3-carboxylic acids with antibacterial activity.
Nishimura Y; Hirose T; Okada H; Shibamori K; Nakano J; Matsumoto J
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2190-6. PubMed ID: 2126225
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of quinolones toward eukaryotic cells. Identification of topoisomerase II as the primary cellular target for the quinolone CP-115,953 in yeast.
Elsea SH; Osheroff N; Nitiss JL
J Biol Chem; 1992 Jul; 267(19):13150-3. PubMed ID: 1320012
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
Miyamoto T; Matsumoto J; Chiba K; Egawa H; Shibamori K; Minamida A; Nishimura Y; Okada H; Kataoka M; Fujita M
J Med Chem; 1990 Jun; 33(6):1645-56. PubMed ID: 2342057
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and antibacterial activity of 5-amino-6, 8-difluoro-1-(5-fluoro-2-pyridyl)-7-(3-methyl-1-piperazinyl)-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues].
Liu JY; Wei YG; Guo HY
Yao Xue Xue Bao; 2001 Jun; 36(6):419-22. PubMed ID: 12585124
[TBL] [Abstract][Full Text] [Related]
19. The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues.
Lawrence LE; Wu P; Fan L; Gouveia KE; Card A; Casperson M; Denbleyker K; Barrett JF
J Antimicrob Chemother; 2001 Aug; 48(2):195-201. PubMed ID: 11481288
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of possible metabolites of 1-cyclopropyl-1,4-dihydro-6-fluoro-5-methyl-7-(3-methyl-1-piperazinyl)- 4-oxo-3-quinolinecarboxylic acid (Grepafloxacin, OPC-17116).
Morita S; Otsubo K; Matsubara J; Ohtani T; Kawano Y; Ohmori K; Ohguro K; Uchida M
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2246-52. PubMed ID: 8582026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
